Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2022

22-06-2021

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

Auteurs: Kyriakos Souliotis, Theodoros V. Giannouchos, Chistina Golna, Evangelos Liberopoulos

Gepubliceerd in: Quality of Life Research | Uitgave 1/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

We estimate the association between forgetfulness to take medications as prescribed and polypharmacy and health-related quality of life (HRQoL) among a cohort of patients with hypertension, dyslipidemia or both in Greece during the COVID-19 pandemic.

Methods

A telephone survey of 1018 randomly selected adults was conducted in Greece in June 2020. Participants were included in the survey, if they (a) had a diagnosis of hypertension, dyslipidemia or both and (b) were on prescription treatment for these conditions. HRQoL was calculated using the short form (SF) -12 Patient Questionnaire. A multivariable generalized linear regression model (GLM) was used to estimate the association between forgetfulness and polypharmacy and HRQoL, controlling for sociodemographic and health-related covariates.

Results

Overall, 351 respondents met the inclusion criteria, of whom 28 did not fully complete the questionnaire (response rate: 92%, n = 323). Of those, 37% were diagnosed with hypertension only, 28% with dyslipidemia only, and 35% with both. Most reported good to average physical (64.1%) and mental health (48.6%). Overall, 25% indicated that they sometimes forget to take their prescribed medications, and 12% took two or more pills multiple times daily. Total HRQoL score was 68.9% (s.d. = 18.0%). About 10% of participants reported paying less attention to their healthcare condition during the pandemic. Estimates of multivariable analyses indicated a negative association between forgetfulness (− 9%, adjusted β: − 0.047, 95% confidence interval − 0.089 to − 0.005, p = 0.029), taking two or more pills multiple times daily compared to one pill once a day (− 16%, adjusted β: − 0.068, 95% confidence interval − 0.129 to − 0.008, p = 0.028) and total HRQoL.

Conclusion

Our results suggest that among adult patients with hypertension, dyslipidemia or both in Greece, those who forget to take their medications and those with more complex treatment regimens had lower HRQoL. Such patients merit special attention and require targeted approaches by healthcare providers to improve treatment compliance and health outcomes.
Literatuur
1.
go back to reference Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 5, 1–5. Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 5, 1–5.
2.
go back to reference Venkitachalam, L., Wang, K., Porath, A., Corbalan, R., Hirsch, A. T., Cohen, D. J., Smith, S. C., Jr., Ohman, E. M., Steg, P. G., Bhatt, D. L., Magnuson, E. A., & REACH Registry Investigators. (2012). Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation, 125(15), 1858–1869.PubMed Venkitachalam, L., Wang, K., Porath, A., Corbalan, R., Hirsch, A. T., Cohen, D. J., Smith, S. C., Jr., Ohman, E. M., Steg, P. G., Bhatt, D. L., Magnuson, E. A., & REACH Registry Investigators. (2012). Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation, 125(15), 1858–1869.PubMed
4.
go back to reference Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., & Taddei, C. (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet, 389(10064), 37–55. Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., & Taddei, C. (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet, 389(10064), 37–55.
5.
go back to reference Taddei, C., Zhou, B., Bixby, H., & NCD Risk Factor Collaboration (NCD-RisC). (2020). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 4(582), 73–77. Taddei, C., Zhou, B., Bixby, H., & NCD Risk Factor Collaboration (NCD-RisC). (2020). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 4(582), 73–77.
6.
go back to reference Panagiotakos, D. B., Georgousopoulou, E. N., Pitsavos, C., Chrysohoou, C., Metaxa, V., Georgiopoulos, G. A., Kalogeropoulou, K., Tousoulis, D., Stefanadis, C., & ATTICA Study group. (2015). Ten-year (2002–2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: The ATTICA study. International Journal of Cardiology, 180, 178–84.PubMed Panagiotakos, D. B., Georgousopoulou, E. N., Pitsavos, C., Chrysohoou, C., Metaxa, V., Georgiopoulos, G. A., Kalogeropoulou, K., Tousoulis, D., Stefanadis, C., & ATTICA Study group. (2015). Ten-year (2002–2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: The ATTICA study. International Journal of Cardiology, 180, 178–84.PubMed
7.
go back to reference Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147.PubMed Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147.PubMed
8.
go back to reference Trevisol, D. J., Moreira, L. B., Kerkhoff, A., Fuchs, S. C., & Fuchs, F. D. (2011). Health-related quality of life and hypertension: A systematic review and meta-analysis of observational studies. Journal of Hypertension, 29(2), 179–188.PubMed Trevisol, D. J., Moreira, L. B., Kerkhoff, A., Fuchs, S. C., & Fuchs, F. D. (2011). Health-related quality of life and hypertension: A systematic review and meta-analysis of observational studies. Journal of Hypertension, 29(2), 179–188.PubMed
11.
go back to reference Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value in Health, 10(6), 443–450.PubMed Sullivan, P. W., Ghushchyan, V., Wyatt, H. R., Wu, E. Q., & Hill, J. O. (2007). Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value in Health, 10(6), 443–450.PubMed
12.
go back to reference Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008). Adherence to Mediterranean diet and health status: Meta-analysis. BMJ, 337, a1344.PubMedPubMedCentral Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008). Adherence to Mediterranean diet and health status: Meta-analysis. BMJ, 337, a1344.PubMedPubMedCentral
13.
go back to reference Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., & Lamuela-Raventos, R. M. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279–1290. Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., & Lamuela-Raventos, R. M. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279–1290.
14.
go back to reference Alexopoulos, D., Anastasiou-Nana, M., Elisaf, M. S., Liberopoulos, E., Rallidis, L. S., Davos, C. H., Moulis, A., Nikas, N., Zacharis, E., Vardas, P., & CHALLENGE Investigators. (2016). A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients’ quality of life in Greece: The CHALLENGE study. International Journal of Cardiology, 217, 183–189.PubMed Alexopoulos, D., Anastasiou-Nana, M., Elisaf, M. S., Liberopoulos, E., Rallidis, L. S., Davos, C. H., Moulis, A., Nikas, N., Zacharis, E., Vardas, P., & CHALLENGE Investigators. (2016). A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients’ quality of life in Greece: The CHALLENGE study. International Journal of Cardiology, 217, 183–189.PubMed
15.
go back to reference Liberopoulos, E., Vlasserou, F., Mitrogianni, Z., Papageorgantas, I., & Elisaf, M. (2012). Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece. Angiology, 63(3), 184–193.PubMed Liberopoulos, E., Vlasserou, F., Mitrogianni, Z., Papageorgantas, I., & Elisaf, M. (2012). Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece. Angiology, 63(3), 184–193.PubMed
16.
go back to reference Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opinion on Drug Safety, 7(6), 717–725.PubMed Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opinion on Drug Safety, 7(6), 717–725.PubMed
17.
go back to reference Lalonde, L., Blais, L., Bérard, A., & Perreault, S. (2010). Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health, 13(1), 87–94.PubMed Lalonde, L., Blais, L., Bérard, A., & Perreault, S. (2010). Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value in Health, 13(1), 87–94.PubMed
18.
go back to reference Schoenthaler, A., Rosenthal, D. M., Butler, M., & Jacobowitz, L. (2018). Medication adherence improvement similar for shared decision-making preference or longer patient-provider relationship. Journal of the American Board of Family Medicine, 31(5), 752–760.PubMed Schoenthaler, A., Rosenthal, D. M., Butler, M., & Jacobowitz, L. (2018). Medication adherence improvement similar for shared decision-making preference or longer patient-provider relationship. Journal of the American Board of Family Medicine, 31(5), 752–760.PubMed
19.
go back to reference Morrison, V. L., Holmes, E. A., Parveen, S., Plumpton, C. O., Clyne, W., De Geest, S., Dobbels, F., Vrijens, B., Kardas, P., & Hughes, D. A. (2015). Predictors of self-reported adherence to antihypertensive medicines: A multinational, cross-sectional survey. Value in Health, 18(2), 206–216.PubMed Morrison, V. L., Holmes, E. A., Parveen, S., Plumpton, C. O., Clyne, W., De Geest, S., Dobbels, F., Vrijens, B., Kardas, P., & Hughes, D. A. (2015). Predictors of self-reported adherence to antihypertensive medicines: A multinational, cross-sectional survey. Value in Health, 18(2), 206–216.PubMed
20.
go back to reference Tsiantou, V., Pantzou, P., Pavi, E., Koulierakis, G., & Kyriopoulos, J. (2010). Factors affecting adherence to antihypertensive medication in Greece: Results from a qualitative study. Patient Preference and Adherence, 4, 335.PubMedPubMedCentral Tsiantou, V., Pantzou, P., Pavi, E., Koulierakis, G., & Kyriopoulos, J. (2010). Factors affecting adherence to antihypertensive medication in Greece: Results from a qualitative study. Patient Preference and Adherence, 4, 335.PubMedPubMedCentral
21.
go back to reference Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Maddox, T. M., Peterson, P. N., Masoudi, F. A., & Rumsfeld, J. S. (2008). Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. American Heart Journal, 155(4), 772–779.PubMed Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Maddox, T. M., Peterson, P. N., Masoudi, F. A., & Rumsfeld, J. S. (2008). Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. American Heart Journal, 155(4), 772–779.PubMed
22.
go back to reference Conn, V. S., Ruppar, T. M., & Cooper, P. S. (2016). Patient-centered outcomes of medication adherence interventions: Systematic review and meta-analysis. Value in Health, 19(2), 277–285.PubMedPubMedCentral Conn, V. S., Ruppar, T. M., & Cooper, P. S. (2016). Patient-centered outcomes of medication adherence interventions: Systematic review and meta-analysis. Value in Health, 19(2), 277–285.PubMedPubMedCentral
24.
go back to reference Bonaventura, M., Copher, R., Basurto, E., Faria, C., & Lorenzo, R. (2014). The association between non-adherence and quality of life among women with metastatic breast cancer. Value in Health, 17(3), A92. Bonaventura, M., Copher, R., Basurto, E., Faria, C., & Lorenzo, R. (2014). The association between non-adherence and quality of life among women with metastatic breast cancer. Value in Health, 17(3), A92.
25.
go back to reference Patrick, A. R., Shrank, W. H., Glynn, R. J., Solomon, D. H., Dormuth, C. R., Avorn, J., Cadarette, S. M., Mogun, H., & Brookhart, M. A. (2011). The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value in Health, 14(4), 513–20.PubMedPubMedCentral Patrick, A. R., Shrank, W. H., Glynn, R. J., Solomon, D. H., Dormuth, C. R., Avorn, J., Cadarette, S. M., Mogun, H., & Brookhart, M. A. (2011). The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value in Health, 14(4), 513–20.PubMedPubMedCentral
26.
go back to reference Jneid, S., Jabbour, H., Hajj, A., Sarkis, A., Licha, H., Hallit, S., & Khabbaz, L. R. (2018). Quality of life and its association with treatment satisfaction, adherence to medication, and trust in physician among patients with hypertension: A cross-sectional designed study. Journal of Cardiovascular Pharmacology and Therapeutics, 23(6), 532–542.PubMed Jneid, S., Jabbour, H., Hajj, A., Sarkis, A., Licha, H., Hallit, S., & Khabbaz, L. R. (2018). Quality of life and its association with treatment satisfaction, adherence to medication, and trust in physician among patients with hypertension: A cross-sectional designed study. Journal of Cardiovascular Pharmacology and Therapeutics, 23(6), 532–542.PubMed
27.
go back to reference Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 1, 521–530. Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 1, 521–530.
28.
go back to reference Silavanich, V., Nathisuwan, S., Phrommintikul, A., & Permsuwan, U. (2019). Relationship of medication adherence and quality of life among heart failure patients. Heart and Lung, 48(2), 105–110.PubMed Silavanich, V., Nathisuwan, S., Phrommintikul, A., & Permsuwan, U. (2019). Relationship of medication adherence and quality of life among heart failure patients. Heart and Lung, 48(2), 105–110.PubMed
29.
go back to reference Zioga, E., Kazakos, K., Dimopoulos, E., Koutras, C., Marmara, K., Marmara, E. E., Marmaras, A., & Lavdaniti, M. (2016). Adherence and quality of life in patients with type II diabetes mellitus in northern Greece. Materia Socio-Medica, 28(4), 258.PubMedPubMedCentral Zioga, E., Kazakos, K., Dimopoulos, E., Koutras, C., Marmara, K., Marmara, E. E., Marmaras, A., & Lavdaniti, M. (2016). Adherence and quality of life in patients with type II diabetes mellitus in northern Greece. Materia Socio-Medica, 28(4), 258.PubMedPubMedCentral
30.
go back to reference Schenker, Y., Park, S. Y., Jeong, K., Pruskowski, J., Kavalieratos, D., Resick, J., Abernethy, A., & Kutner, J. S. (2019). Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness. Journal of General Internal Medicine, 34(4), 559–66.PubMedPubMedCentral Schenker, Y., Park, S. Y., Jeong, K., Pruskowski, J., Kavalieratos, D., Resick, J., Abernethy, A., & Kutner, J. S. (2019). Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness. Journal of General Internal Medicine, 34(4), 559–66.PubMedPubMedCentral
31.
go back to reference Vyas, A., Kang, F., & Barbour, M. (2020). Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors. Quality of Life Research, 29(4), 977–986.PubMed Vyas, A., Kang, F., & Barbour, M. (2020). Association between polypharmacy and health-related quality of life among US adults with cardiometabolic risk factors. Quality of Life Research, 29(4), 977–986.PubMed
32.
go back to reference Vyas, A., Alghaith, G., & Hufstader-Gabriel, M. (2020). Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: A population-level analysis. Quality of Life Research, 29(8), 2029–2037.PubMed Vyas, A., Alghaith, G., & Hufstader-Gabriel, M. (2020). Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: A population-level analysis. Quality of Life Research, 29(8), 2029–2037.PubMed
33.
go back to reference Martínez, Y. V., Prado-Aguilar, C. A., Rascón-Pacheco, R. A., & Valdivia-Martínez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8(1), 164.PubMedPubMedCentral Martínez, Y. V., Prado-Aguilar, C. A., Rascón-Pacheco, R. A., & Valdivia-Martínez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8(1), 164.PubMedPubMedCentral
34.
go back to reference Yfantopoulos, J. N., & Chantzaras, A. (2018). Drug policy in Greece. Value Health Regional Issues, 1(16), 66–73. Yfantopoulos, J. N., & Chantzaras, A. (2018). Drug policy in Greece. Value Health Regional Issues, 1(16), 66–73.
36.
go back to reference Anderson, K. E., McGinty, E. E., Presskreischer, R., & Barry, C. L. (2021). Reports of forgone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Network Open, 4(1), e2034882.PubMedPubMedCentral Anderson, K. E., McGinty, E. E., Presskreischer, R., & Barry, C. L. (2021). Reports of forgone medical care among US adults during the initial phase of the COVID-19 pandemic. JAMA Network Open, 4(1), e2034882.PubMedPubMedCentral
37.
go back to reference Pineda-Sic, R. A., Galarza-Delgado, D. A., Serna-Peña, G., Castillo-Torres, S. A., Flores-Alvarado, D. E., Esquivel-Valerio, J. A., & Hernández-Galarza, I. D. (2021). Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience. Annals of the Rheumatic Diseases, 80(6), e85. Pineda-Sic, R. A., Galarza-Delgado, D. A., Serna-Peña, G., Castillo-Torres, S. A., Flores-Alvarado, D. E., Esquivel-Valerio, J. A., & Hernández-Galarza, I. D. (2021). Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience. Annals of the Rheumatic Diseases, 80(6), e85.
38.
go back to reference Fragoulis, G. E., Evangelatos, G., Arida, A., Bournia, V. K., Fragiadaki, K., Karamanakos, A., Kravvariti, E., Laskari, K., Panopoulos, S., Pappa, M., & Tektonidou, M. G. (2021). Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Annals of the Rheumatic Diseases, 80(4), e60. Fragoulis, G. E., Evangelatos, G., Arida, A., Bournia, V. K., Fragiadaki, K., Karamanakos, A., Kravvariti, E., Laskari, K., Panopoulos, S., Pappa, M., & Tektonidou, M. G. (2021). Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Annals of the Rheumatic Diseases, 80(4), e60.
39.
go back to reference Kaye, L., Theye, B., Smeenk, I., Gondalia, R., Barrett, M. A., & Stempel, D. A. (2020). Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology: In Practice, 8(7), 2384–2385.PubMed Kaye, L., Theye, B., Smeenk, I., Gondalia, R., Barrett, M. A., & Stempel, D. A. (2020). Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. The Journal of Allergy and Clinical Immunology: In Practice, 8(7), 2384–2385.PubMed
40.
go back to reference Betcherman, G., Giannakopoulos, N., Laliotis, I., Pantelaiou, I., Testaverde, M., & Tzimas, G. (2020). Reacting quickly and protecting jobs: The short-term impacts of the COVID-19 lockdown on the Greek labor market. Washington: World Bank. Betcherman, G., Giannakopoulos, N., Laliotis, I., Pantelaiou, I., Testaverde, M., & Tzimas, G. (2020). Reacting quickly and protecting jobs: The short-term impacts of the COVID-19 lockdown on the Greek labor market. Washington: World Bank.
41.
go back to reference Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., & Sullivan, M. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51, 1171–8.PubMed Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., & Sullivan, M. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51, 1171–8.PubMed
42.
go back to reference Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 1, 851–859. Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 1, 851–859.
43.
go back to reference Kontodimopoulos, N., Pappa, E., Niakas, D., & Tountas, Y. (2007). Validity of SF-12 summary scores in a Greek general population. Health and Quality of Life Outcomes, 5(1), 1–9. Kontodimopoulos, N., Pappa, E., Niakas, D., & Tountas, Y. (2007). Validity of SF-12 summary scores in a Greek general population. Health and Quality of Life Outcomes, 5(1), 1–9.
44.
go back to reference Nguyen, T. M., Caze, A. L., & Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445.PubMedPubMedCentral Nguyen, T. M., Caze, A. L., & Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445.PubMedPubMedCentral
45.
go back to reference Giannouchos, T. V., Biskupiak, J., Moss, M. J., Brixner, D., Andreyeva, E., & Ukert, B. (2021). Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. American Journal of Emergency Medicine, 40, 20–6. Giannouchos, T. V., Biskupiak, J., Moss, M. J., Brixner, D., Andreyeva, E., & Ukert, B. (2021). Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system. American Journal of Emergency Medicine, 40, 20–6.
46.
go back to reference Chew, B. H. (2015). Medication adherence on quality of life among adults with type 2 diabetes mellitus: An exploratory analysis on the EDDMQoL study. Quality of Life Research, 24(11), 2723–2731.PubMed Chew, B. H. (2015). Medication adherence on quality of life among adults with type 2 diabetes mellitus: An exploratory analysis on the EDDMQoL study. Quality of Life Research, 24(11), 2723–2731.PubMed
47.
go back to reference Khayyat, S. M., Mohamed, M. M., Khayyat, S. M., Alhazmi, R. S., Korani, M. F., Allugmani, E. B., Saleh, S. F., Mansouri, D. A., Lamfon, Q. A., Beshiri, O. M., & Hadi, M. A. (2019). Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: A cross-sectional survey. Quality of Life Research, 28(4), 1053–61.PubMed Khayyat, S. M., Mohamed, M. M., Khayyat, S. M., Alhazmi, R. S., Korani, M. F., Allugmani, E. B., Saleh, S. F., Mansouri, D. A., Lamfon, Q. A., Beshiri, O. M., & Hadi, M. A. (2019). Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: A cross-sectional survey. Quality of Life Research, 28(4), 1053–61.PubMed
48.
go back to reference Bulloch, A. G., Adair, C. E., & Patten, S. B. (2006). Forgetfulness: A role in noncompliance with antidepressant treatment. Canadian Journal of Psychiatry, 51(11), 719–722.PubMed Bulloch, A. G., Adair, C. E., & Patten, S. B. (2006). Forgetfulness: A role in noncompliance with antidepressant treatment. Canadian Journal of Psychiatry, 51(11), 719–722.PubMed
49.
go back to reference Park, H. Y., Seo, S. A., Yoo, H., & Lee, K. (2018). Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Preference and Adherence, 12, 175.PubMedPubMedCentral Park, H. Y., Seo, S. A., Yoo, H., & Lee, K. (2018). Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Preference and Adherence, 12, 175.PubMedPubMedCentral
50.
go back to reference Weidenbacher, H. J., Beadles, C. A., Maciejewski, M. L., Reeve, B. B., & Voils, C. I. (2015). Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: The association with depressive symptom burden in a sample of American veterans. Patient Preference and Adherence, 9, 327.PubMedPubMedCentral Weidenbacher, H. J., Beadles, C. A., Maciejewski, M. L., Reeve, B. B., & Voils, C. I. (2015). Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: The association with depressive symptom burden in a sample of American veterans. Patient Preference and Adherence, 9, 327.PubMedPubMedCentral
51.
go back to reference Karakurt, P., & Kaşikçi, M. (2012). Factors affecting medication adherence in patients with hypertension. Journal of Vascular Nursing, 30(4), 118–126.PubMed Karakurt, P., & Kaşikçi, M. (2012). Factors affecting medication adherence in patients with hypertension. Journal of Vascular Nursing, 30(4), 118–126.PubMed
52.
go back to reference Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., & Haynes, R. B. (2014). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD000011.pub4CrossRef Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., & Haynes, R. B. (2014). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. https://​doi.​org/​10.​1002/​14651858.​CD000011.​pub4CrossRef
53.
go back to reference Pages-Puigdemont, N., Mangues, M. A., Masip, M., Gabriele, G., Fernández-Maldonado, L., Blancafort, S., & Tuneu, L. (2016). Patients’ perspective of medication adherence in chronic conditions: A qualitative study. Advances in Therapy, 33(10), 1740–54.PubMedPubMedCentral Pages-Puigdemont, N., Mangues, M. A., Masip, M., Gabriele, G., Fernández-Maldonado, L., Blancafort, S., & Tuneu, L. (2016). Patients’ perspective of medication adherence in chronic conditions: A qualitative study. Advances in Therapy, 33(10), 1740–54.PubMedPubMedCentral
54.
go back to reference Montori, V. M., Brito, J. P., & Murad, M. H. (2013). The optimal practice of evidence-based medicine: Incorporating patient preferences in practice guidelines. JAMA, 310(23), 2503–2504.PubMed Montori, V. M., Brito, J. P., & Murad, M. H. (2013). The optimal practice of evidence-based medicine: Incorporating patient preferences in practice guidelines. JAMA, 310(23), 2503–2504.PubMed
55.
go back to reference Aschmann, H. E., Boyd, C. M., Robbins, C. W., Chan, W. V., Mularski, R. A., Bennett, W. L., Sheehan, O. C., Wilson, R. F., Bayliss, E. A., Leff, B., & Armacost, K. (2020). Informing patient-centered care through stakeholder engagement and highly stratified quantitative benefit-harm assessments. Value in Health, 23(5), 616–624.PubMed Aschmann, H. E., Boyd, C. M., Robbins, C. W., Chan, W. V., Mularski, R. A., Bennett, W. L., Sheehan, O. C., Wilson, R. F., Bayliss, E. A., Leff, B., & Armacost, K. (2020). Informing patient-centered care through stakeholder engagement and highly stratified quantitative benefit-harm assessments. Value in Health, 23(5), 616–624.PubMed
56.
go back to reference Witticke, D., Seidling, H. M., Klimm, H. D., & Haefeli, W. E. (2012). Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Preference and Adherence, 6, 679.PubMedPubMedCentral Witticke, D., Seidling, H. M., Klimm, H. D., & Haefeli, W. E. (2012). Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Preference and Adherence, 6, 679.PubMedPubMedCentral
57.
go back to reference Choi, A., Lovett, A. W., Kang, J., Lee, K., & Choi, L. (2015). Mobile applications to improve medication adherence: Existing apps, quality of life and future directions. Advances in Pharmacology and Pharmacy, 3(3), 64–74. Choi, A., Lovett, A. W., Kang, J., Lee, K., & Choi, L. (2015). Mobile applications to improve medication adherence: Existing apps, quality of life and future directions. Advances in Pharmacology and Pharmacy, 3(3), 64–74.
58.
go back to reference Patel, S., Jacobus-Kantor, L., Marshall, L., Ritchie, C., Kaplinski, M., Khurana, P. S., & Katz, R. J. (2013). Mobilizing your medications: An automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. Journal of Diabetes Science and Technology, 7(3), 630–639.PubMedPubMedCentral Patel, S., Jacobus-Kantor, L., Marshall, L., Ritchie, C., Kaplinski, M., Khurana, P. S., & Katz, R. J. (2013). Mobilizing your medications: An automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. Journal of Diabetes Science and Technology, 7(3), 630–639.PubMedPubMedCentral
59.
go back to reference Grimm, R. H., Grandits, G. A., Cutler, J. A., Stewart, A. L., McDonald, R. H., Svendsen, K., Prineas, R. J., & Liebson, P. R. (1997). Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Archives of Internal Medicine, 157(6), 638–648.PubMed Grimm, R. H., Grandits, G. A., Cutler, J. A., Stewart, A. L., McDonald, R. H., Svendsen, K., Prineas, R. J., & Liebson, P. R. (1997). Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Archives of Internal Medicine, 157(6), 638–648.PubMed
60.
go back to reference Katsi, V., Kallistratos, M. S., Kontoangelos, K., Sakkas, P., Souliotis, K., Tsioufis, C., Nihoyannopoulos, P., Papadimitriou, G. N., & Tousoulis, D. (2017). Arterial hypertension and health-related quality of life. Frontiers in Psychiatry, 8, 270.PubMedPubMedCentral Katsi, V., Kallistratos, M. S., Kontoangelos, K., Sakkas, P., Souliotis, K., Tsioufis, C., Nihoyannopoulos, P., Papadimitriou, G. N., & Tousoulis, D. (2017). Arterial hypertension and health-related quality of life. Frontiers in Psychiatry, 8, 270.PubMedPubMedCentral
61.
go back to reference Park, N. H., Song, M. S., Shin, S. Y., Jeong, J. H., & Lee, H. Y. (2018). The effects of medication adherence and health literacy on health-related quality of life in older people with hypertension. International Journal of Older People Nursing, 13(3), e12196.PubMed Park, N. H., Song, M. S., Shin, S. Y., Jeong, J. H., & Lee, H. Y. (2018). The effects of medication adherence and health literacy on health-related quality of life in older people with hypertension. International Journal of Older People Nursing, 13(3), e12196.PubMed
62.
go back to reference Papadopoulos, A. A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., & Niakas, D. (2007). Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health, 7(1), 186.PubMedPubMedCentral Papadopoulos, A. A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., & Niakas, D. (2007). Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health, 7(1), 186.PubMedPubMedCentral
Metagegevens
Titel
Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic
Auteurs
Kyriakos Souliotis
Theodoros V. Giannouchos
Chistina Golna
Evangelos Liberopoulos
Publicatiedatum
22-06-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02917-y

Andere artikelen Uitgave 1/2022

Quality of Life Research 1/2022 Naar de uitgave